Calumet's Q2 Masked a Real Turnaround: $175M EBITDA Rose, but Net Loss Could Still Scare the Crowd

Q2 looked worse on paper than it did operationally

The first thing investors will notice is the headline loss: Calumet reported a Q2 net loss of $95.9 million and a basic loss per share of $1.09. But the more important detail is why that loss happened. The company said the result was driven by non-cash RINs and other mark-to-market items, not by an obvious breakdown in operations.

Adjusted EBITDA tells the better story

The quarter was much healthier than the GAAP loss suggests. Calumet generated $175 million of Q2 Adjusted EBITDA, after $50.1 million in first-quarter adjusted EBITDA. That improvement suggests better throughput and a better margin environment as operational issues ease. It does not mean all pressures are gone, but it does show where the real momentum was.

If the market starts focusing on operating profit instead of accounting noise, the stock could rerate. If another quarter comes in with a large net loss, however, investors may stop treating the issue as temporary. After a 2025 full year that still ended in a net loss, the next test is whether management can keep showing that operating gains are becoming more visible and more durable.

Calumet's two-segment model improved in Q2

Calumet is not dependent on one narrow profit center. One segment manufactures and markets specialty products in more than 80 countries and roughly 2,400 customers; the other converts renewable feedstock into sustainable aviation fuel at scale. In Q2, both parts of the business looked healthier than the headline net loss implied.

Specialties did most of the work

The clearest sign was Specialty Products and Solutions generated $161.7 million of Adjusted EBITDA. That was more than double the prior-year level, helped by pricing, record production, higher fuel margins, and tight global base-oil markets.

That improvement also did not appear out of nowhere. The backdrop had been improving after Shreveport resumed normal operations in early April, after Montana Renewables commenced MaxSAF 150 operations in early May, and after the EPA's March SET2 RVO. Q2 looks less like a random bounce and more like those earlier operational and policy catalysts starting to compound.

SAF is moving from launch to scale

The renewable fuels side is no longer only a future-tense story. Montana Renewables is now set to supply up to 30 million gallons of neat SAF through the Minnesota SAF Hub. Management also expects SAF output to rise through the year, which matters because scale only becomes compelling if it turns into actual volume and cash flow.

Performance Brands remains the weak spot

The weaker side of the model still slipped. Performance Brands Adjusted EBITDA fell to $6.3 million as rising input costs outpaced pricing and created a $7 million LIFO-related headwind. Management still framed that weakness as timing-related and expects it to improve as pricing catches up. For now, the stronger specialties segment is doing most of the heavy lifting.

What matters next is straightforward: - Whether specialties EBITDA can stay near this level if margin tailwinds persist - Whether SAF volumes move closer to management's year-end run-rate target - Whether the weaker unit stops holding back the broader report

Debt reduction matters as much as the operating rebound

The balance sheet is the key follow-through test. A refiner-marketer with meaningful debt can absorb one bad GAAP quarter, but it has less room to maneuver if cash generation weakens as well.

Calumet has already started reducing leverage by calling $100 million of notes and repurchasing $115 million of truck-rack sale-leaseback debt. As a result, restricted-group leverage fell below 4x, and management said it should be back above 3x next quarter. That does not eliminate risk, but it does improve breathing room and reduce refinancing pressure if RINs or mark-to-market items continue to cloud headline earnings.

What would confirm the turnaround

• Specialty Products and Solutions Adjusted EBITDA remains strong enough to suggest the quarter was repeatable rather than a one-off margin spike.
• SAF scaling continues toward management's year-end run-rate target, showing the second bucket is becoming more than a narrative.
• Leverage keeps improving while non-cash RINs and other mark-to-market items remain primarily an earnings-formatting issue rather than a sign of broader business stress.

What would break the case

• Specialties stops doing the heavy lifting and Performance Brands stays weak, leaving the softer segment to drag down the report.
• SAF milestones slip, so MaxSAF 150 improvements do not translate into volume or cash flow.
• Leverage stops improving or the company continues to need balance-sheet support while another net loss is explained mainly by accounting noise.

The bull case, then, is not that Calumet posted clean earnings. It is that the operating quarter improved materially, debt is coming down, and the main drag on reported profit looks more like accounting distortion than a broken business. The bear case is simple: if that pattern repeats next quarter, the market may stop giving the company the benefit of the doubt.